BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamilton G, Schlein AN, Wolfson T, Cunha GM, Fowler KJ, Middleton MS, Loomba R, Sirlin CB. The relationship between liver triglyceride composition and proton density fat fraction as assessed by 1 H MRS. NMR Biomed 2020;33:e4286. [PMID: 32128921 DOI: 10.1002/nbm.4286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Willis SA, Malaikah S, Parry S, Bawden S, Ennequin G, Sargeant JA, Yates T, Webb DR, Davies MJ, Stensel DJ, Aithal GP, King JA. The effect of acute and chronic exercise on hepatic lipid composition. Scand J Med Sci Sports 2023. [PMID: 36610000 DOI: 10.1111/sms.14310] [Reference Citation Analysis]
2 Zhong L, Li M, Du X, Ding Y, Zhang X, Mei Y, Yi P, Feng Y, Chen Y, Zhang X. Quantitative evaluation of the characteristic of infrapatellar fat pad Fat Content and Unsaturation Index by using hydrogen proton MR spectroscopy. Magnetic Resonance Imaging 2022. [DOI: 10.1016/j.mri.2022.07.014] [Reference Citation Analysis]
3 Sebastiani G, Patel K, Ratziu V, Feld JJ, Neuschwander-tetri BA, Pinzani M, Petta S, Berzigotti A, Metrakos P, Shoukry N, Brunt EM, Tang A, Cobbold JF, Ekoe J, Seto K, Ghali P, Chevalier S, Anstee QM, Watson H, Bajaj H, Stone J, Swain MG, Ramji A. Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH). CanLivJ 2022;5:61-90. [DOI: 10.3138/canlivj-2021-0030] [Reference Citation Analysis]
4 Bydder M, Chavez T, Lam J, Henderson W, Pinto N, Chavarria R, Pham AD, Loomba R, Schwimmer J, Sirlin C, Hamilton G. Triglyceride Saturation in Patients at Risk of NASH and NAFLD: A Cross-Sectional Study. Biophysica 2021;2:8-15. [DOI: 10.3390/biophysica2010002] [Reference Citation Analysis]
5 Willis SA, Bawden SJ, Malaikah S, Sargeant JA, Stensel DJ, Aithal GP, King JA. The role of hepatic lipid composition in obesity-related metabolic disease. Liver Int 2021;41:2819-35. [PMID: 34547171 DOI: 10.1111/liv.15059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Pasanta D, Htun KT, Pan J, Tungjai M, Kaewjaeng S, Kim H, Kaewkhao J, Kothan S. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics (Basel) 2021;11:842. [PMID: 34067193 DOI: 10.3390/diagnostics11050842] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Xavier A, Arteaga de Castro C, Andia ME, Luijten PR, Klomp DW, Fillmer A, Prompers JJ. Metabolite cycled liver 1 H MRS on a 7 T parallel transmit system. NMR Biomed 2020;33:e4343. [PMID: 32515151 DOI: 10.1002/nbm.4343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]